Scientific Research
-
.
Structural and signaling mechanisms of TAAR1 enabled preferential agonist design.
Cell,
186,
5347-5362.e24,
2024.
-
.
Target-based drug design strategies to overcome resistance to antiviral agents: opportunities and challenges.
DRUG RESISTANCE UPDATES,
73,
2024.
-
.
Revolutionizing viral disease treatment: Phase separation and lysosome/exosome targeting as new areas and new paradigms for antiviral drug research.
Drug Discov Today.,
29,
2024.
-
.
Identification of a small-molecule Tim-3 inhibitor to potentiate T cell-mediated antitumor immunotherapy in preclinical mouse models.
SCIENCE TRANSLATIONAL MEDICINE,
15,
2024.
-
.
SARS-CoV-2 NSP5 and N protein counteract the RIG-I signaling pathway by suppressing the formation of stress granules.
SIGNAL TRANSDUCTION AND TARGETED THERAPY,
2023.
-
黄伯世.
Structure-Based Design and Discovery of Pyridyl-Bearing Fused Bicyclic HIV-1 Inhibitors: Synthesis, Biological Characterization, and Molecular Modeling Studies.
Journal of Medicianal Chemistry,
64,
13604-13621,
2023.